Pediatrics

Latest News

FDA Committee Recommends Sanofi/AstraZeneca’s RSV Vaccine for Infants
FDA Committee Recommends Sanofi/AstraZeneca’s RSV Vaccine for Infants

June 12th 2023

If approved, nirsevimab would be the first immunization specifically to protect infants through their first RSV season. The Prescription Drug User Fee Act date is in the third quarter of 2023.

FDA Approves First Pediatric Indication for Blockbuster Eylea
FDA Approves First Pediatric Indication for Blockbuster Eylea

February 9th 2023

FDA Accepts BLA for RSV Prevention in Infants
FDA Accepts BLA for RSV Prevention in Infants

January 5th 2023

Wegovy Approved for Teens; Supply May be Delayed
Wegovy Approved for Teens; Supply May be Delayed

January 4th 2023

AbbVie Submits sNDA for Linzess for Children and Adolescents
AbbVie Submits sNDA for Linzess for Children and Adolescents

December 17th 2022

More News

© 2024 MJH Life Sciences

All rights reserved.